Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway) Secondary to PTSD (Treated with SSRIs Causing Weight Gain)
Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway) can develop as a service-connected secondary condition to PTSD (Treated with SSRIs Causing Weight Gain) when a medical nexus links the two under 38 CFR § 3.310. The strength of medical evidence for this specific pairing is moderate. Multiple medications used for PTSD treatment cause clinically significant weight gain, which is the primary modifiable risk factor for obstructive sleep apnea.
How is Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway) connected to PTSD (Treated with SSRIs Causing Weight Gain)?
Multiple medications used for PTSD treatment cause clinically significant weight gain, which is the primary modifiable risk factor for obstructive sleep apnea. Atypical antipsychotics prescribed for PTSD-related nightmares and hyperarousal (mirtazapine, quetiapine, olanzapine, risperidone) cause weight gain through H1 histamine receptor antagonism (increased appetite and carbohydrate craving) and 5-HT2C blockade (reduced satiety signaling). Paroxetine (an SSRI) causes more weight gain than other SSRIs. Mood stabilizers such as valproate cause significant weight gain via insulin resistance. Each 10 kg of weight gain increases the odds of OSA by 6-fold through increased peripharyngeal fat deposition, reduced functional residual lung capacity, and worsened upper airway critical closing pressure. This creates a valid medication-mediated nexus chain: PTSD → medication → weight gain → OSA.
“Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected.”
What evidence supports claiming Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway) as secondary to PTSD (Treated with SSRIs Causing Weight Gain)?
Wetterling T (2001) Drug Saf (antipsychotic weight gain); Apovian CM et al. (2003) Obes Res (psychotropic weight gain mechanisms); Peppard PE et al. (2013) Am J Epidemiol (weight gain and OSA incidence); Young T et al. (2005) Epidemiology (body weight and OSA).
How do I file a secondary claim for Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway)?
Weight records from medical files documenting weight gain temporally correlated with PTSD medication initiation. Prescription records documenting the weight-gain-causing medication. Polysomnography documenting OSA. A nexus letter from a sleep medicine physician or internist addressing the medication-induced weight gain as the proximate cause of OSA development strengthens the claim. This is a two-step nexus (PTSD → medication-induced weight gain → OSA) that is legally valid under 38 CFR § 3.310 as the OSA is proximately due to the PTSD-required treatment.
How does the VA rate Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway)?
Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway) is rated under 38 CFR Part 4 using the diagnostic code assigned to that condition. The VA evaluates the severity of the secondary condition independently and assigns a rating from 0% to 100% in increments defined in the rating schedule. That rating is then combined with PTSD (Treated with SSRIs Causing Weight Gain) and all other service-connected conditions using the combined ratings formula under § 4.25.
Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway) is rated under DC 6847 in 38 CFR Part 4.
Common Questions — Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway) Secondary to PTSD (Treated with SSRIs Causing Weight Gain)
Can Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway) be claimed as secondary to PTSD (Treated with SSRIs Causing Weight Gain)?
Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway) is a documented secondary pairing for PTSD (Treated with SSRIs Causing Weight Gain) with moderate medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.
What evidence proves Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway) is caused by PTSD (Treated with SSRIs Causing Weight Gain)?
The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.
Does the VA combine or separately rate Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway)?
The VA rates Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway) separately under its own 38 CFR Part 4 diagnostic code, then combines it with PTSD (Treated with SSRIs Causing Weight Gain) and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.
What legal standard applies to secondary service connection?
38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.
How strong is the medical evidence for this pairing?
The medical evidence supporting Weight Gain → Obstructive Sleep Apnea (Medication-Induced Pathway) as secondary to PTSD (Treated with SSRIs Causing Weight Gain) is rated moderate. Multiple medications used for PTSD treatment cause clinically significant weight gain, which is the primary modifiable risk factor for obstructive sleep apnea. Atypical antipsychotics prescribed for PTSD-related nightmares and hyperarousal (mirtazapine, quetiapine, olanzapine, risperidone) cause weight gain through H1 histamine receptor antagonism (increased appetite and carbohydrate craving) and 5-HT2C blockade (reduced satiety signaling). Paroxetine (an SSRI) causes more weight gain than other SSRIs. Mood stabilizers such as valproate cause significant weight gain via insulin resistance. Each 10 kg of weight gain increases the odds of OSA by 6-fold through increased peripharyngeal fat deposition, reduced functional residual lung capacity, and worsened upper airway critical closing pressure. This creates a valid medication-mediated nexus chain: PTSD → medication → weight gain → OSA.
Do I need a nexus letter for a secondary claim?
The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.
Get a Full Secondary Condition Analysis
VeteranHQ cross-references your complete medical history against the full secondary condition database, surfacing every secondary claim opportunity for your specific service-connected conditions.
Start Your Free Analysis